Do Infectious Diseases After Kidney Retransplantation Differ From Those After First Kidney Transplantation?

"Potential conflicts of interest. P. W. S. received travel grants from Pfizer and Gilead, speaker's honorary from Pfizer, and fees for advisory board activity from Pfizer and Gilead outside the submitted work. All other authors report no potential conflicts."

"Financial support. This work was supported by the academic career program Filling the Gap of the Medical Faculty of the University of Zurich (to P. W. S.). This study was performed in the framework of the Swiss Transplant Cohort Study, supported by the Swiss National Science Foundation, the Swiss University Hospitals (G15), and transplant centers. Financial support."

"This study was a nested project within the STCS (www.stcs.ch; ClinicalTrials.gov, NCT01204944). The STCS has been prospectively collecting data from all Swiss transplant centers since May 2008 (Basel, Bern, Geneva, St Gallen, Lausanne, and Zurich). Enrollment in the STCS encompasses >93% of all transplant recipients in Switzerland []. In predefined time intervals, transplant recipients are followed up by dedicated research assistants to obtain information on the occurrence of ID events."